Humbert M, Guignabert C, Bonnet S, Dorfmüller P, Klinger JR, Nicolls MR, Olschewski AJ, Pullamsetti SS, Schermuly RT, Stenmark KR, Rabinovitch M. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019;53:1801887.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tonelli AR, Arelli V, Minai OA, Newman J, Bair N, Heresi GA, Dweik RA. Causes and circumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013;188:365–9.

Article  PubMed  PubMed Central  Google Scholar 

Oudiz RJ. Death in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013;188:269–70.

Article  PubMed  Google Scholar 

Chang KY, Duval S, Badesch DB, Bull TM, Chakinala MM, De Marco T, Frantz RP, Hemnes A, Mathai SC, Rosenzweig EB, Ryan JJ, Thenappan T, PHAR Investigators *. Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry. J Am Heart Assoc. 2022;11:e024969.

Ross DJ, Hough G, Hama S, Aboulhosn J, Belperio JA, Saggar R, Van Lenten BJ, Ardehali A, Eghbali M, Reddy S, Fogelman AM, Navab M. Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension. Pulm Circ. 2015;5:640–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruffenach G, O’Connor E, Vaillancourt M, Hong J, Cao N, Sarji S, Moazeni S, Papesh J, Grijalva V, Cunningham CM, Shu L, Chattopadhyay A, Tiwari S, Mercier O, Perros F, Umar S, Yang X, Gomes AV, Fogelman AM, Reddy ST, Eghbali M. Oral 15-hydroxyeicosatetraenoic acid induces pulmonary hypertension in mice by triggering T cell-dependent endothelial cell apoptosis. Hypertension. 2020;76:985–96.

Article  CAS  PubMed  Google Scholar 

Sharma S, Ruffenach G, Umar S, Motayagheni N, Reddy ST, Eghbali M. Role of oxidized lipids in pulmonary arterial hypertension. Pulm Circ. 2016;6:261–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma S, Umar S, Potus F, Iorga A, Wong G, Meriwether D, Breuils-Bonnet S, Mai D, Navab K, Ross D, Navab M, Provencher S, Fogelman AM, Bonnet S, Reddy ST, Eghbali M. Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p. Circulation. 2014;130:776–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhong S, Li L, Shen X, Li Q, Xu W, Wang X, Tao Y, Yin H. An update on lipid oxidation and inflammation in cardiovascular diseases. Free Radic Biol Med. 2019;144:266–78.

Article  CAS  PubMed  Google Scholar 

Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States—PubMed [Internet]. [cited 2023 Apr 25]; https://pubmed.ncbi.nlm.nih.gov/28267855/

Anselmi G, Gagliardi L, Egidi G, Leone S, Gasbarrini A, Miggiano GAD, Galiuto L. Gut microbiota and cardiovascular diseases: a critical review. Cardiol Rev. 2021;29:195.

Article  PubMed  Google Scholar 

Benson TW, Conrad KA, Li XS, Wang Z, Helsley RN, Schugar RC, Coughlin TM, Wadding-Lee C, Fleifil S, Russell HM, Stone T, Brooks M, Buffa JA, Mani K, Björck M, Wanhainen A, Sangwan N, Biddinger S, Bhandari R, Ademoya A, Pascual C, Tang WHW, Tranter M, Cameron SJ, Brown JM, Hazen SL, Owens AP. Gut Microbiota-derived trimethylamine N-oxide contributes to abdominal aortic aneurysm through inflammatory and apoptotic mechanisms. Circulation. 2023;147:1079–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trøseid M, Andersen GØ, Broch K, Hov JR. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions. EBioMedicine. 2020;52: 102649.

Article  PubMed  PubMed Central  Google Scholar 

Masenga SK, Hamooya B, Hangoma J, Hayumbu V, Ertuglu LA, Ishimwe J, Rahman S, Saleem M, Laffer CL, Elijovich F, Kirabo A. Recent advances in modulation of cardiovascular diseases by the gut microbiota. J Hum Hypertens. 2022;36:952–9.

Article  PubMed  PubMed Central  Google Scholar 

Shi CY, Yu CH, Yu WY, Ying HZ. Gut-lung microbiota in chronic pulmonary diseases: evolution, pathogenesis, and therapeutics. Can J Infect Dis Med Microbiol. 2021;2021:9278441.

Article  PubMed  PubMed Central  Google Scholar 

Cheng W-L, Chang C-C, Luo C-S, Chen K-Y, Yeh Y-K, Zheng J-Q, Wu S-M. Targeting lung-gut axis for regulating pollution particle-mediated inflammation and metabolic disorders. Cells. 2023;12:901.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marsland BJ, Trompette A, Gollwitzer ES. The Gut-Lung Axis in Respiratory Disease. Ann Am Thorac Soc. 2015;12(Suppl 2):S150-156.

Article  PubMed  Google Scholar 

GEO Accession viewer [Internet]. [cited 2023 Apr 25]; https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117261

Stearman RS, Bui QM, Speyer G, Handen A, Cornelius AR, Graham BB, Kim S, Mickler EA, Tuder RM, Chan SY, Geraci MW. Systems analysis of the human pulmonary arterial hypertension lung transcriptome. Am J Respir Cell Mol Biol. 2019;60:637–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Romanoski CE, Qi X, Sangam S, Vanderpool RR, Stearman RS, Conklin A, Gonzalez-Garay M, Rischard F, Ayon RJ, Wang J, Simonson T, Babicheva A, Shi Y, Tang H, Makino A, Kanthi Y, Geraci MW, Garcia JGN, Yuan JX-J, Desai AA. Transcriptomic profiles in pulmonary arterial hypertension associate with disease severity and identify novel candidate genes. Pulm Circ. 2020;10:2045894020968531.

Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21.

Article  CAS  PubMed  Google Scholar 

Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.

Article  PubMed  PubMed Central  Google Scholar 

C C, Ae B, Sc M, Dn G, Tn W, Y S, S B, J F, M B, L H, Al Z, R G, Ma M, Ra J, F W, Kc B, Pm H. Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patients. PloS one [Internet]. 2012 [cited 2023 Apr 25];7. https://pubmed.ncbi.nlm.nih.gov/22545094/

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43: e47.

Article  PubMed  PubMed Central  Google Scholar 

Carbon S, Ireland A, Mungall CJ, Shu S, Marshall B, Lewis S, AmiGO Hub, Web Presence Working Group. AmiGO: online access to ontology and annotation data. Bioinformatics. 2009;25:288–289.

Pan H, Wang X, Huang W, Dai Y, Yang M, Liang H, Wu X, Zhang L, Huang W, Yuan L, Wu Y, Wang Y, Liao L, Huang J, Guan J. Interferon-induced protein 44 correlated with immune infiltration serves as a potential prognostic indicator in head and neck squamous cell carcinoma. Front Oncol. 2020;10: 557157.

Article  PubMed  PubMed Central  Google Scholar 

Savale L, Chaumais M-C, O’Connell C, Humbert M, Sitbon O. Interferon-induced pulmonary hypertension: an update. Curr Opin Pulm Med. 2016;22:415–20.

Article  CAS  PubMed  Google Scholar 

Cunningham CM, Li M, Ruffenach G, Doshi M, Aryan L, Hong J, Park J, Hrncir H, Medzikovic L, Umar S, Arnold AP, Eghbali M. Y-Chromosome Gene, Uty, protects against pulmonary hypertension by reducing proinflammatory chemokines. Am J Respir Crit Care Med. 2022;206:186–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li N, Dai Z, Wang Z, Deng Z, Zhang J, Pu J, Cao W, Pan T, Zhou Y, Yang Z, Li J, Li B, Ran P. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease. Respir Res. 2021;22:274.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Keely S, Talley NJ, Hansbro PM. Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol. 2012;5:7–18.

Article  CAS  PubMed  Google Scholar 

Lewis CV, Taylor WR. Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease. Am J Physiol-Heart Circulatory Physiol. 2020;319:H1227–33.

Article  CAS  Google Scholar 

Girosi D, Bellodi S, Sabatini F, Rossi GA. The lung and the gut: common origins, close links. Paediatr Respir Rev. 2006;7(Suppl 1):S235-239.

Article  PubMed  Google Scholar 

Raftery AL, Tsantikos E, Harris NL, Hibbs ML. Links between inflammatory bowel disease and chronic obstructive pulmonary disease. Front Immunol. 2020;11:2144.

Article  CAS  PubMed  PubMed Central